Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky
Moscow, Moscow Oblast, 129110, Russia
NCT Number: NCT06700330
The aim of this research is to study the etiology, the clinical picture, the management, the complications and the outcomes of necrotic pancreatitis in children.
Currently, there is a significant number of errors in the early diagnosis of AP in children associated with the complexity of differential diagnosis, which leads to the untimely verification of the correct diagnosis and, consequently, to incorrect treatment tactics, which could be accompanied by an increase in the severe forms of the disease and an increase in mortality.
Looking for future studies?
Notify Me0 year–18 year
All sexes
Observational
Moscow, Moscow Oblast, 129110, Russia
Acute pancreatitis (AP) is an acute inflammatory disease of the exocrine pancreas. Clinical manifestations vary from mild abdominal discomfort to metabolic disorders, sepsis, fluid sequestration, multiple organ failure and death. According to the international data, the annual incidence of AP in children is 3-13 cases per 100,000 people, but in recent years, there has been an increase in the incidence of this pathology. Necrotic pancreatitis in children accounts for up to 25-30% of the cases of all forms of AP. Despite the successes achieved in the diagnosis and treatment of AP, the mortality rate for this pathology is up to 5%, according to various authors. In addition, given the varying degrees of the prevalence of the destructive process in the pancreas and the parapancreatic tissue, the choice of surgical treatment still remains a subject of discussion. The treatment of moderately severe (MSAP) and severe (SAP) necrotic pancreatitis is a complex task due to the variety of causes of the disease, the incompletely understood pathogenesis and the uncertainty in predicting the results.
Paralytic ileus with the development of intestinal failure is the main pathogenetic factor in the development of a septic condition in AP, but there is tendency of insufficient attention being paid to this fact in pediatric practice, which determines the lack of a unified approach to the treatment of intestinal failure syndrome.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Only data from the patient file.
Time frame: From enrollment to the end of treatment (2 month)
based on the study, the most common causes of necrotizing pancreatitis in children will be identified
Time frame: from the onset of the disease to the end of treatment (up to 20 weeks)
Time frame: from admission to hospital until the end of treatment (up to 8 weeks)
the effect of each risk factor on the duration of hospital stay
Time frame: During ICU stay (up to 60 days)
Time frame: from admission to hospital until the end of treatment (up to 8 weeks)
Time frame: from admission to hospital until the end of treatment (up to 8 weeks)
the effect of Intestinal failure on the duration of hospital stay
Time frame: from admission to hospital until the end of treatment (up to 8 weeks)
the effect of paralytic ileus on the severity of acute pancreatitis and the length of hospital stay
Time frame: from admission to hospital until the end of treatment (up to 20 weeks)
Time frame: from admission to hospital until the end of treatment (up to 10 weeks)
the effect on severity of the disease and the outcome
Time frame: from admission to hospital until the end of treatment (up to 20 weeks)
the effect on severity of the disease and the outcome
Time frame: from admission to hospital until the end of treatment (up to 20 weeks)
Time frame: from admission to hospital until the end of treatment (up to 20 weeks)
Moscow Regional Research and Clinical Institute (MONIKI)
Other Gov
Study of the Etiology, Clinical Picture, Complications and Outcomes of Necrotizing Pancreatitis in Children.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07106346
Acute Necrotic Collection, Digestive System Diseases
Aichi, Japan
View Trial DetailsNCT03253861
Acute Necrotizing Pancreatitis, Digestive System Diseases
Nantes, France
View Trial DetailsNCT07599605
Digestive System Diseases, ERCP
Chihuahua City, Chihuahua, Mexico
View Trial DetailsNCT06721572
Abdominal Pain, Chronic Disease
Ann Arbor, Michigan, United States
View Trial Details